Technology Transfer Office News & Events

Entrepreneur-in-Residence Meet & Greet

When: Wednesday, July 12, 2017, 2:00 – 3:30 PM
Where: Pharmacy Building, Room 205

Concordia University is pleased that Loren Peterson, an experienced local entrepreneur, has been engaged to serve as Concordia’s Entrepreneur-in-Residence on a part-time basis effective June 15, 2017.In this new role, it is intended that Loren will support Concordia’s process for evaluating technologies for commercialization; assist with business development and patent commercialization activities; meet with faculty innovators to discuss commercialization and new venture formation; and, where appropriate, provide coaching and mentoring on enterprise launch, fund raising, market entry and other topics pertaining to the creation of new entrepreneurial ventures.

Loren is an entrepreneurial advisor and founder of EAS-MKE, LLC, a consulting firm working with institutions of higher education as well as their faculty and students on strategies and tactics for developing and commercializing innovative research, often through the formation of new companies established for this purpose. He has extensive operational experience with small-to-medium-sized businesses and has successfully financed and grown several drug development companies. Prior to forming EAS-MKE, Loren was a Managing Director and Chief Financial Officer for Venture Investors, LLC, a leading venture capital firms in the Midwest, focused on making seed and early stage healthcare and technology investments. Loren was responsible for all operations of the company’s capital partnerships including investor relations, financial reporting, legal, accounting, valuation analyses, and audit and tax compliance and issues. Earlier in his career, he worked for 15 years as a CPA and another 17 years as an executive in the pharmaceutical and drug development industry, which includes serving as President, CEO and Director of Milwaukee-based ZyStor Therapeutics from 2003 until 2010, when it was acquired by a large pharmaceutical company.

Julie Dresen, Director

Dan McCollum, Assistant Director

Kala Zornow, Grants Accountant